上海谊众股价涨6.03%，华安基金旗下1只基金重仓，持有3962股浮盈赚取1.24万元

Group 1 - Shanghai Yizhong Pharmaceutical Co., Ltd. has seen its stock price increase by 6.03% to 55.00 CNY per share, with a total market capitalization of 11.369 billion CNY as of January 9 [1] - The company has experienced a continuous stock price increase for six days, with a cumulative increase of 11.45% during this period [1] - The main business of Shanghai Yizhong involves the research and industrialization of modified new anti-tumor drugs, with 99.84% of its revenue coming from injectable paclitaxel polymer micelles [1] Group 2 - Huashan Fund holds a significant position in Shanghai Yizhong, with its Huashan CSI 1000 Index Enhanced A Fund (015148) owning 3,962 shares, representing 0.4% of the fund's net value [2] - The fund has generated a floating profit of approximately 12,400 CNY today and a total of 21,100 CNY during the six-day stock price increase [2] - The Huashan CSI 1000 Index Enhanced A Fund was established on July 12, 2022, with a current scale of 45.938 million CNY and a year-to-date return of 5.53% [2]